Security key
29446K106
Equillium, Inc. - Common Stock, par value $0.0001 per share (EQ)
CUSIP: 29446K106
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 29,653,795
- Total 13F value
- $42,404,231
- Share change
- +20,944,744
- SEC-reported price per share
- $1.43
- Number of holders
- 40
- Value change
- +$30,732,112
- Number of buys
- 28
- Number of sells
- 14
- Shares outstanding
- 66,704,586
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
40
Top holders
10
EQ full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Equillium, Inc. SEC filings
Equillium, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 29446K106
Recent filing periods:
Ownership snapshot
Top reported holders of EQ - Equillium, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Adage Capital Management,...
Disclosed value leader
Adage Capital Management,...
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G
13F
Lead comparable stake: 10%
13D/G row: Adage Capital Management, L.P.
Showing 1-6 of 15 holder rows.
Quick read
Adage Capital Management, L.P. leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Adage Capital Management, L.P.'s linked filing trail.
Comparable ownership
Top 5
Adage Capital Management, L.P.
10%
Woodline Partners LP
5.9%
Decheng Capital LLC
6.7%
TAKEDA PHARMACEUTICAL CO LTD
2.7%
VANGUARD GROUP INC
1.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Adage Capital Management, L.P. |
13D/G
|
10%
|
$8,596,850
6,012,624 shares
|
$0 | 30 Sep 2025 |
| Woodline Partners LP |
13D/G
|
5.9%
|
$5,016,841
3,508,771 shares
|
$0 | 30 Sep 2025 |
| Decheng Capital LLC |
13F
Company
|
6.7%
|
$1,401,792
4,447,308 shares
|
— | 30 Jun 2025 |
| TAKEDA PHARMACEUTICAL CO LTD |
13F
Company
|
2.7%
|
$575,233
1,824,977 shares
|
— | 30 Jun 2025 |
| VANGUARD GROUP INC |
13F
Company
|
1.2%
|
$259,588
824,091 shares
|
— | 30 Jun 2025 |
| Cota Capital Management, LLC |
13F
Company
|
0.84%
|
$177,230
562,278 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
40
Shares
29,653,795
Rows available
40
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
27
Q3 2025 holders
40
Holder diff
13
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend